viimane versioon :
19/11/2024
antibiootikum   Ceftazidime  
Silmatilgad
Süsteravim
Stabiilsust ravimpreparaadid Stabiilsust mõjutavad tegurid stabiilsust mõjutavad faktorid Sobimatus Viited pdf
   keemiline struktuur  

Silmatilgad
Viited   Silmatilgad   Viited : Ceftazidime  
tüüp avaldamine
2708 ajaleht Barnes AR, Nash R.
Stability of ceftazidime in a viscous eye drop formulation
J Clin Pharm Ther 1999 ; 24: 299-302
2717 ajaleht Barnes AR.
Determination of ceftazidime and pyridine by HPLC: application to a viscous eye drop formulation.
J Liquid Chrom 1995 ; 18: 3117-3128.
3289 ajaleht Kodym A, Hapka-Zmich D, Golab M, Gwizdala M.
Stability of ceftazidime in 1% and 5% buffered eye drops determined by HPLC method.
Acta Pol Pharm 2011 ; 68, 1: 99-107.
4041 plakat Jobard M, Brandely-Piat M-L, El Deeb G, Labat L, Cros C, Chast F, Batista R.
Etude de stabilité d'un collyre de ceftazidime à 50mg/ml conditionné en flacon de polyéthylène basse densité.
SNPHPU Congress 12th 2017
4197 ajaleht Gautier E, Saillard J, Deshayes C, Vrignaud S, Lagarce F, Briot T.
Stability of a 50 mg/mL Ceftazidime Eye-Drops Formulation.
Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,4:219-226
4264 ajaleht Karampatakis V, Papanikolaou T, Giannousis M, Goulas A, Mandraveli K, Kilmpasani M, Alexiou-Daniel S, Mirtsou-Fidani V.
Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus.
Acta Ophtalmol 2008

  Mentions Légales